South America Cardiovascular Devices Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Device [Electrocardiography (ECG), Pacemaker, Stent, Defibrillator, Cardiac Catheter, Guidewire, Heart Valve, Event Monitor, and Others], Application (Coronary Heart Disease, Sudden Cardiac Arrest, Stroke, Cerebrovascular Heart Disease, and Others), and End User (Hospitals, Ambulatory Surgery Centers, and Cardiac Centers)

The South America cardiovascular devices market is expected to reach US$ 3,061.07 million by 2028 from US$ 2,054.15 million in 2021. The market is estimated to grow at a CAGR of 5.9% from 2021 to 2028.

The rise in the incidence of cardiovascular conditions in developing countries is ascribed to the shift in lifestyles and adoption of modernized facilities, leading to an increase in the prevalence of other health conditions associated with Cardiovascular Devices. The modernization of residential, commercial, and corporate facilities has lowered the need for physical activities among people; in contrast, stress levels among people are rising due to various personal and social factors, which are driving the prevalence of Cardiovascular Devices in developing countries. Moreover, these countries are bringing significant developments in healthcare facilities and services, based on technological advancements.The South America cardiovascular devices market is expected to grow at a good CAGR during the forecast period.

South America Cardiovascular Devices Revenue and Forecast to 2028 (US$ Million)  

South America Cardiovascular Devices Market Segmentation   

The South America cardiovascular devices market is segmented into device, application, end user, and country. Based on device, the market is segmented into electrocardiography (ECG), pacemaker, stent, defibrillator, cardiac catheter, guidewire, heart valve, event monitor, and others. The event monitor segment dominated the market in 2020. In terms of application, the market is segmented into coronary heart disease, sudden cardiac arrest, stroke, cerebrovascular heart disease, and others. The coronary heart disease segment dominated the market in 2020. Based on end user, the South America cardiovascular devices market is segmented into hospitals, ambulatory surgery centers, and cardiac centers. The hospitals segment dominated the market in 2020. Based on country, the South America cardiovascular devices market is segmented into Brazil, Argentina, and the Rest of South America. Brazil dominated the South America cardiovascular devices market in 2020.

Medtronic, Boston Scientific Corporation, Abbott, Johnson and Johnson Service Inc, General Electric Company, Koninklijke Philips N.V, Siemens Healthineers AG, BD, B. Braun Melsungen AG,  and Edwards Lifesciences Corporation are among the leading companies in the South America cardiovascular devices market.

1. Medtronic.
2. Boston Scientific Corporation.
3. Abbott.
4. Jhonson and Jhonson Service Inc.
5. General Electric Company.
6. Koninlijke Philips N.V.
7. Siemens Healthineers AG.
8. BD.
9. B.Bruna melsungen AG.
10. Edwards Lifesciences Corporation. 

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South America Cardiovascular Devices market forecast.   
• Highlights key business priorities in order to assist companies to realign their business strategies
• The key findings and recommendations highlight crucial progressive industry trends in South America Cardiovascular Devices market forecast, thereby allowing players across the value chain to develop effective long-term strategies
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
• Scrutinize in-depth South America market trends and outlook coupled with the factors driving the cardiovascular devices market, as well as those hindering it.
• Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.